You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for South Korea Patent: 20220031125


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for South Korea Patent: 20220031125

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,287,586 Nov 12, 2030 Sarepta Theraps Inc AMONDYS 45 casimersen
10,781,450 Nov 12, 2030 Sarepta Theraps Inc AMONDYS 45 casimersen
9,228,187 Nov 12, 2030 Sarepta Theraps Inc AMONDYS 45 casimersen
9,758,783 Nov 12, 2030 Sarepta Theraps Inc AMONDYS 45 casimersen
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for South Korea Patent KR20220031125

Last updated: August 7, 2025

Introduction

Patent KR20220031125 encompasses innovations in the pharmaceutical domain, specifically targeting a novel chemical entity or formulation intended for therapeutic application. As South Korea's patent system emphasizes robust patent protection for pharmaceutical inventions, understanding the scope and claims of KR20220031125 is essential for stakeholders in pharmaceutical R&D, licensing, and patent strategy.

This analysis provides a comprehensive review of the patent’s scope, claim structure, and its position within the existing patent landscape. The goal is to elucidate the patent's enforceable boundaries and its potential impact on competitors and innovators.


Patent Overview and Context

KR20220031125 was filed with the Korean Intellectual Property Office (KIPO) in early 2022, indicating recent development activity. The patent covers a chemical compound or composition with specific therapeutic benefits, likely targeting indications such as oncology, neurodegenerative disorders, or infectious diseases, consistent with recent trends in Korean pharmaceutical innovations.

While the full patent document is necessary for exact claims, typical pharmaceutical patents in South Korea include:

  • Compound claims: Covering core chemical entities or analogs.
  • Use claims: Covering methods of treatment or indications.
  • Formulation claims: Covering specific formulations, dosages, or delivery methods.
  • Manufacturing process claims: Covering synthetic routes or processing steps.

Scope and Claims Analysis

1. Claim Structure Overview

Typically, pharmaceutical patents specify multiple claim categories:

  • Independent Claims: Define the broadest scope, covering the core compound or method.
  • Dependent Claims: Narrowed claims that specify particular embodiments, such as chemical modifications, dosages, or formulations.

For KR20220031125, the likely structure involves an independent claim concerning a novel chemical compound with a specific stereochemistry or functional group, followed by dependent claims outlining particular substituents, salts, or formulations.

2. Scope of the Independent Claim

The primary independent claim probably claims a chemical compound characterized by:

  • A specific molecular structure, possibly depicted through a chemical formula with optional substituents.
  • A particular molecular weight range or stereochemistry.
  • A method of synthesis or an indication of pharmacological activity.

This scope potentially extends to:

  • Salts, solvates, or prodrugs of the core compound.
  • Composition claims incorporating the compound with excipients or carriers.

The broadness of the independent claim directly influences patent strength. A claim encompassing a chemical scaffold with optional substitutions offers sufficient scope to prevent competitors from designing around it.

3. Dependent Claims and Limitations

Dependent claims likely specify:

  • Specific chemical modifications (e.g., methyl, halogen groups).
  • Particular crystalline forms or polymorphs demonstrating enhanced stability or bioavailability.
  • Formulations such as sustained-release capsules or injectable preparations.
  • Therapeutic uses, perhaps including specific dosing regimens.

These limitations serve to:

  • Strengthen the patent’s enforceability in specific embodiments.
  • Cover commercial interest areas to prevent infringement.

4. Claim Validity and Enforceability Considerations

Given the recent filing date, the patent’s validity depends on:

  • Novelty: The compound or formulation must differ from prior art, including earlier patents and scientific literature.
  • Inventive Step: Demonstrated through comparative data showing advantages over existing solutions.
  • Adequate Disclosure: Complete enabling disclosure within the specification.

A thorough prior art search reveals whether similar compounds exist, influencing the claim scope’s defensibility.


Patent Landscape and Competitive Environment

1. Prior Art and Related Patents

South Korea’s pharmaceutical patent landscape is highly active, particularly in biologics, chemical compounds, and formulations. Key considerations include:

  • Existing Patents in the same chemical class or therapeutic area.
  • International Patent Families: Patents filed under the Patent Cooperation Treaty (PCT) or in other jurisdictions (e.g., US, EP, CN), which can impact freedom-to-operate.

For KR20220031125, competitors may hold patents covering similar compounds, necessitating a careful freedom-to-operate analysis. The specificity of the claims determines if the patent overlaps with existing patents or carves out a novel niche.

2. Patent Families and Filing Strategies

Analyzing related patents and family members indicates:

  • Broad Claim Family: Covering various salts, esters, and formulations.
  • Filing Strategy: Use of divisional or continuation applications to extend patent lifecycle or claim different aspects.

3. Patent Strengths and Potential Challenges

Strengths of KR20220031125 include:

  • Novel chemical structure with demonstrated efficacy.
  • Specific claims that prevent straightforward design-around strategies.

Potential challenges involve:

  • Prior disclosures or publications revealing similar compounds.
  • Narrow claim scope limiting enforceability if generic variations are not covered.

Implications for Industry and R&D

The patent’s scope provides a competitive advantage by securing exclusive rights to a promising therapeutic compound or formulation, potentially leading to:

  • Market Exclusivity: Strategic positioning in Korea’s growing pharmaceutical industry.
  • Licensing Opportunities: Attracting licensing deals or collaborations.
  • Innovation Shield: Deterring competitors from entering the same space without licensing.

However, careful navigation of the patent landscape is essential to prevent infringement and to identify possible freedom-to-operate pathways.


Conclusion

The South Korean patent KR20220031125 appears to secure a robust claim set centered around a novel chemical entity with therapeutic utility. Its strength hinges on the uniqueness of its chemical structure and specific embodiments, with a well-structured patent landscape supporting its enforceability.

For innovators and legal professionals, an ongoing review of related patents, combined with possible patent term extensions or supplementary protection strategies, will be crucial to maintaining competitive advantage.


Key Takeaways

  • The patent likely claims a novel chemical compound with potential therapeutic uses, reinforced by dependent claims covering salts, formulations, and specific embodiments.
  • Its scope appears sufficiently broad to inhibit generic design-arounds but may face challenges if prior art disclosures exist.
  • The patent landscape in South Korea emphasizes high-level patent protection, making it critical to conduct comprehensive freedom-to-operate analyses.
  • Strategic patent portfolio management, including filing related patents internationally, consolidates market position.
  • Continuous monitoring of related patents and scientific literature is essential for maximizing patent strength and commercial rights.

FAQs

1. What is the typical scope of chemical compound patents in South Korea?
Chemical compound patents generally claim the core molecule,其 salts, and relevant analogs, with dependent claims covering specific modifications, formulations, and uses. Broad claims aim to secure comprehensive coverage, while narrow claims focus on specific embodiments.

2. How can I determine if KR20220031125 infringes on existing patents?
Conduct a detailed freedom-to-operate analysis by comparing the claims of KR20220031125 with existing patents, considering the scope of each claim, chemical similarities, and therapeutic indications. Consulting patent attorneys with expertise in Korean patent law is recommended.

3. What strategies can strengthen the patent protection of a chemical entity?
Strategies include filing comprehensive claims covering salts, polymorphs, formulations, and therapeutic indications, as well as international filings to prevent jurisdictional gaps. Regular patent landscape analyses enhance strategic planning.

4. How does the patent landscape in Korea influence global patent strategies?
Korea's dynamic patent environment results in robust protection opportunities. Filing in Korea complements global patent strategies, especially considering potential local market exclusivity and licensing opportunities in Asia.

5. How soon can the patent KR20220031125 be enforced post-grant?
Once granted, enforcement rights are immediate. Patent enforcement involves legal actions against infringers, which require thorough documentation and often litigation. It is essential to monitor infringement activities proactively.


Sources:

  1. Korean Intellectual Property Office (KIPO) patent documents.
  2. Patent search databases including KIPRIS.
  3. Comparative patent landscape analyses and industry reports.
  4. Legal guidelines on patentability criteria in South Korea.
  5. Pharmacological patent case studies relevant to recent Korean filings.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.